|Bid||256.91 x 900|
|Ask||256.94 x 800|
|Day's range||256.43 - 258.45|
|52-week range||183.86 - 259.01|
|PE ratio (TTM)||22.64|
|Earnings date||17 Jul 2018|
|Forward dividend & yield||3.60 (1.44%)|
|1y target est||280.33|
UnitedHealth (UNH) should see an increase in Public Group and International business, partially offset by lower commercial membership.
With Johnson & Johnson (JNJ) and Novartis AG (NVS) scheduled to report on Jul 17 and Jul 18, respectively, this may be a good time to figure out which of these is a better stock.
Breakouts were scarce Tuesday once the negative reversals among oil stocks were culled out. A handful of oil stocks cleared buy points and then reversed lower.
the Dow Jones closed above its 50-day moving average for the first time in nearly three weeks, a positive sign for its short-term momentum trend. As such, its proxy version DIA is in the spotlight heading into the earnings season.
UnitedHealth's (UNH) arm forges an alliance with Community Care for providing better and cost-efficient care in North Carolina.
UnitedHealth Group (UNH) paid a cash dividend of $0.90 per share on June 26 to its shareholders of record at the close of business on June 18. The dividend represented an increase of 20.0% over its quarterly dividend of $0.75 paid during the second quarter of 2017.
UnitedHealth Group (UNH) is one of the leading healthcare companies in the world, offering healthcare products and insurance services. The company has posted steady stock price performance over the last year. Of the 23 analysts covering UNH stock on June 29, 11 gave “strong buy” recommendations.
The 30-stock Dow Jones industrial average is outperforming on the final day of the second quarter. But small caps still hold a stronger year-to-date advance.
Amazon.com’s (AMZN) announcement yesterday that it would buy pharmacy startup PillPack has had quite an effect on the stocks of drug distributors and managed care, and the Street today is picking through the wreckage, arguing for a selective treatment of different parts of the industry. Shares of the pharmacy names were the hardest hit, with Rite Aid (RAD), for example, down 13% since Wednesday’s close, Walgreens Boots Alliance (WBA) down 10%, and CVS (CVS) down 7%. Names in the "pharmacy benefit management” and managed care market have been spared the worse, with Express Scripts (ESRX) down 1.6% since Wednesday and Aetna (AET) down 2.3%, and Cigna (CI) down just 1.3%.
Lyfebulb LLC and UnitedHealth Group (UNH) have selected 11 Patient Entrepreneur finalists who will compete in the “Empowering Patients: An Innovation Challenge” to earn the Lyfebulb and UnitedHealth Group Innovation Award.
The group of mutual funds is highly rated for outperforming the S&P 500 health-care sectorBloombergBecton, Dickinson CEO Vincent Forlenza on the floor of the New York Stock Exchange. Becton, Dickinson is among the top 10 holdings of four of five health-care funds with the highest ratings from Morningstar.
In this article I am going to calculate the intrinsic value of UnitedHealth Group Incorporated (NYSE:UNH) by taking the expected future cash flows and discounting them to their present value.Read More...
When the CEOs of Amazon.com (AMZN), Berkshire Hathaway (BRK.A), and JPMorgan Chase (JPM) announced on Jan. 30 that they were joining forces to create a not-for-profit health care venture to reduce costs and improve care for their companies’ 1.1 million employees, shares of health care companies tumbled. Jan. 30, 2018 performance: UnitedHealth Group (UNH) -4.4% Anthem (ANTM) -5.3% Aetna (AET) -3.0% Humana (HUM) -3.1% CVS Health (CVS) -4.1% Walgreens Boots (WBA) -5.2% Express Scripts Holding Company (ESRX) -3.2% Cardinal Health (CAH) -1.8% Investors were afraid the new initiative would disrupt the health care industry as we know it, with the announcement explaining that the focus would be on using technology to “provide U.S. employees and their families with simplified, high-quality and transparent health care at a reasonable cost.” That wording, backed by the collective clout of Jeff Bezos, Warren Buffett, and Jamie Dimon, was enough to spook health care investors into dumping their shares.